Maxigen Biotech Inc. announced the appointment of Lin Yung-Hsiang to the Company's Nomination Committee, with effect from May 3, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
45.6 TWD | +1.56% | +7.04% | -5.79% |
1st Jan change | Capi. | |
---|---|---|
-5.79% | 125M | |
+0.03% | 260B | |
+16.33% | 19.96B | |
0.00% | 19.45B | |
+19.21% | 12.92B | |
+21.45% | 7.85B | |
+9.98% | 5.95B | |
-11.55% | 3.9B | |
-1.37% | 3.82B | |
-20.29% | 3.68B |
- Stock Market
- Equities
- 1783 Stock
- News Maxigen Biotech Inc.
- Maxigen Biotech Inc. Appoints Lin Yung-Hsiang to Nomination Committee